A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of ...

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.

Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

Researchers at the University of Colorado Anschutz Medical Campus have discovered that some CAR-T cells engineered to fight ...

A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients ...

Researchers have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria, viruses and other antigens within them, a finding ...

Scientists have discovered significant discrepancies in PD-1 between humans and rodents, indicating that common lab models ...